CSIMarket
 


X4 Pharmaceuticals Inc  (XFOR)
Other Ticker:  
 

X4 Pharmaceuticals Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for X4 Pharmaceuticals Inc in the first quarter 2024?
X4 Pharmaceuticals Inc recorded a cumulative net loss of $-134 million during 12 months ending in the first quarter 2024, resulting in a negative return on equity (ROE) of -284.93%.

Within the Biotechnology & Pharmaceuticals industry 27 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 1712, from total ROE ranking in the third quarter 2023 at 2639.

What is ROE?



Return On Equity (Mar 31 2024)
I. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
III. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change -98.6 % 9.29 % 124.57 % 3.95 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -134 -111 -131 -96 -96
Return On Equity (TTM) -284.93 % -170.43 % -204.94 % -176.81 % -178.8 %
XFOR's Total Ranking # 1712 # 2639 # 3779 # 1536 #
Equity (TTM) in Millions 1 68 68 52 74
Seq. Equity Change -98.47 % 0.09 % 30.69 % -30.22 % 19.73 %
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry # 28
Sector # 237
Overall # 1712

Return On Equity Statistics
High Average Low
-16.37 %
-123.7 %
-284.93 %
(Mar 31 2018)   (Mar 31 2024)





XFOR Annual Return On Equity (Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
Total Equity in Millions 74 64 73 129 22
Y / Y Equity Change 14.96 % -11.52 % -43.66 % 498.24 % -
Net Income in Millions -96 -103 -62 -53 -43
Y / Y Net Income Change - - - - -
Return On Equity -130.2 % -159.35 % -85.35 % -40.87 % -199.17 %





More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
XFOR's' Return on Equity at Yahoo Finance
XFOR's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for XFOR's Competitors
Return On Equity for X4 Pharmaceuticals Inc's Suppliers
Roe for XFOR's Customers




Companies with similar Return On Equity at Mar 31 2024, within Healthcare Sector ROE


Date modified: 2024-05-08T15:34:55+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com